Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Avricore Health (AVCRF) Current Deferred Revenue (2020 - 2023)

Avricore Health has reported Current Deferred Revenue over the past 3 years, most recently at -$185103.0 for Q4 2023.

  • Quarterly Current Deferred Revenue fell 199.71% to -$185103.0 in Q4 2023 from the year-ago period, while the trailing twelve-month figure was -$185103.0 through Dec 2023, down 199.71% year-over-year, with the annual reading at -$186773.9 for FY2023, 196.36% down from the prior year.
  • Current Deferred Revenue was -$185103.0 for Q4 2023 at Avricore Health, up from -$187974.5 in the prior quarter.
  • Over five years, Current Deferred Revenue peaked at $185649.1 in Q4 2022 and troughed at -$187974.5 in Q3 2023.
  • The 3-year median for Current Deferred Revenue is -$185753.2 (2023), against an average of -$88371.5.
  • The largest YoY upside for Current Deferred Revenue was 199.71% in 2023 against a maximum downside of 199.71% in 2023.
  • A 3-year view of Current Deferred Revenue shows it stood at $31205.1 in 2020, then soared by 494.93% to $185649.1 in 2022, then plummeted by 199.71% to -$185103.0 in 2023.
  • Per Business Quant, the three most recent readings for AVCRF's Current Deferred Revenue are -$185103.0 (Q4 2023), -$187974.5 (Q3 2023), and -$187602.0 (Q2 2023).